Streptococcus pyogens from apporva shastri

Reading File
Finding Sources
Finding Sources
Searching PubMed

"Streptococcus pyogenes"[MeSH Terms]

Reading File
Reading File
Searching Images

Streptococcus pyogenes Gram stain beta hemolysis blood agar

Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Searching Images

streptococci chains Gram stain beta-hemolytic colonies

Reading File
I couldn't find Apurba Sastry's Essentials of Medical Microbiology in my library, which I assume is the book you mean. The notes below come from Jawetz 28e and Sherris 8e, organised in the usual exam-note order.

Streptococcus pyogenes (Group A Streptococcus, GAS)

Morphology and culture

  • It is a Gram-positive coccus that is spherical or ovoid and arranged in chains. The cocci divide in a plane perpendicular to the chain axis. Old or dying cultures can stain Gram-negative. (Jawetz Melnick & Adelbergs Medical Microbiology 28e, p. 222)
  • Most strains have a hyaluronic acid capsule, which is antiphagocytic. It is most obvious in young cultures. (Jawetz 28e, p. 222)
  • It grows poorly unless the medium is enriched with blood or tissue fluids. Growth and hemolysis improve in 10% CO2, and the optimum temperature is 37°C. (Jawetz 28e, p. 222)
  • On blood agar the colonies are small and surrounded by a sharp zone of β-hemolysis. (Jawetz 28e, p. 223)
  • It is PYR-positive and usually bacitracin-sensitive. (Jawetz 28e, p. 222)
  • Matte colonies make a lot of M protein and are virulent. Glossy colonies make little M protein and are usually avirulent. (Jawetz 28e, p. 223)
  • β-hemolysis comes from streptolysin S (oxygen-stable) and streptolysin O (oxygen-labile). Strains lacking streptolysin S are β-hemolytic only anaerobically. Such strains are missed if plates are incubated only aerobically. (Sherris & Ryan's Medical Microbiology 8e, p. 1000-1001)

Antigenic structure

  • Cell wall: the group-specific C carbohydrate is the basis of Lancefield grouping. The wall also contains the proteins M, T and R, and peptidoglycan.
  • M protein is the major virulence factor. (Jawetz 28e, p. 223)
    • It is a filamentous, coiled-coil molecule projecting from the cell wall.
    • It resists phagocytosis by inhibiting activation of the alternative complement pathway.
    • There are more than 100 to 150 M types. Immunity is type-specific, so repeat infections with different M types are possible.
    • Class I M protein cross-reacts with cardiac muscle and is linked to rheumatic fever.
  • Other adhesins: lipoteichoic acid and protein F bind fibronectin on epithelial cells. (Sherris 8e, p. 1001-1002)

Toxins and enzymes (Jawetz 28e, p. 223-224)

ProductAction
StreptokinaseConverts plasminogen to plasmin, which digests fibrin and lets the bacteria escape clots
DNases A to DLiquefy pus and aid spread; anti-DNase B is useful after skin infection
Hyaluronidase"Spreading factor" that splits hyaluronic acid
Pyrogenic exotoxins (SpeA, B, C)Superantigens that cause scarlet fever and streptococcal toxic shock syndrome. SpeA and SpeC are phage-encoded; SpeB is a protease
Streptolysin OOxygen-labile and antigenic, giving the basis of the ASO test
Streptolysin SOxygen-stable and non-antigenic

Diseases (Jawetz 28e, p. 224-226)

1. Suppurative, invasive
  • Erysipelas: raised, red lesion with a sharply demarcated, rapidly advancing edge.
  • Cellulitis: not raised, with an indistinct border.
  • Necrotizing fasciitis ("streptococcal gangrene").
  • Puerperal fever.
  • Bacteremia and sepsis.
  • Streptococcal toxic shock syndrome: mainly M types 1 and 3, SpeA-producing strains.
2. Local infections
  • Pharyngitis is the commonest. It presents with tonsillitis, purulent exudate, tender cervical nodes and high fever, and about 20% of infections are asymptomatic.
  • Scarlet fever: pharyngitis plus an erythrogenic toxin rash.
  • Pyoderma (impetigo): superficial vesicles that become pustular and crusted. It is highly communicable in hot, humid climates.
3. Non-suppurative sequelae
  • Acute glomerulonephritis
    • It follows pharyngitis or skin infection.
    • It is caused by immune complexes (SpeB and a nephritis-associated plasmin receptor).
    • Findings are hematuria, proteinuria, edema, hypertension and low complement.
    • Penicillin does not reverse it. Prophylaxis is not used because few nephritogenic types exist.
  • Acute rheumatic fever (ARF)
    • It follows pharyngitis (not skin infection) by 1 to 5 weeks, with a mean of 19 days.
    • It comes from molecular mimicry, with cross-reaction to heart tissue.
    • Features are fever, migratory polyarthritis, carditis (with Aschoff bodies in the myocardium), and Sydenham's chorea.
    • It tends to recur with repeated streptococcal infection, and cardiac damage worsens with each attack.
    • The M types most often involved are 1, 3, 5, 6 and 18.
  • PANDAS is a proposed post-streptococcal neuropsychiatric disorder, and the link is not firmly established.

Laboratory diagnosis (Jawetz 28e, p. 226)

  • Specimens: throat swab, pus, blood, CSF or other sterile fluid, and serum for antibodies.
  • Smear: Gram stain of a throat swab is rarely useful because viridans streptococci look identical.
  • Culture: blood agar, with stab inoculation or CO2 to enhance hemolysis.
  • Identification: PYR test, Lancefield group A antigen detection, and bacitracin sensitivity (presumptive only).
  • Rapid antigen detection test (RADT): 60 to 90% sensitive and 98 to 99% specific. Nucleic acid amplification tests are more sensitive but cost more.
  • Serology: ASO is most useful after respiratory infection. Anti-DNase B and anti-hyaluronidase are best after skin infection. A high ASO titer (>250 units) suggests recent or repeated infection and is commoner in rheumatic patients. The titers show infection, not immunity.

Treatment and prevention (Jawetz 28e, p. 226-227)

  • Treatment: all strains remain uniformly sensitive to penicillin G. Give a 10-day course so that the antigenic stimulus is eliminated before about day 8, which prevents sequelae.
  • Penicillin allergy: macrolides or clindamycin, but macrolide resistance is rising.
  • Antibiotics do not affect established glomerulonephritis or ARF.
  • Secondary prophylaxis after ARF: benzathine penicillin G IM every 3 to 4 weeks, or daily oral penicillin or a sulfonamide. It is continued for years.
  • Control: treat the human source early. Droplets and nasal discharge from carriers and infected people are the main route of spread.

Recent evidence update

Three 2024 systematic reviews from PubMed are relevant:
  • One finds that S. pyogenes is often a passenger rather than a pathogen in uncomplicated sore throat (PMID 38762046).
  • One covers antibiotics for eradicating pharyngeal carriage in asymptomatic people (PMID 38360357).
  • One covers strain diversity and vaccine development (PMID 38070538).
None contradicts the textbook account above, but they refine how to interpret a positive throat culture and the case for treating carriers.
If you send the Sastry chapter text or its headings, I can match these notes to its exact structure. I can also build a one-page revision table or practice MCQs if you'd like.
This is a shared conversation. Sign in to Orris to start your own chat.